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Abstract  
Portal vein thrombosis is a relatively rare but well-known complication of cirrhosis that has a prevalence of between 1% and 5.7%. On the 
contrary, in case of hepatocellular carcinoma (HCC), it is a much more frequent complication. In this paper, we presented three cases that had 
liver cirrhosis, mass and portal vein thrombosis in liver. We were not able to diagnose the cases through imaging methods, laboratory results or 
histopathologically, however, they were diagnosed with endoscopic ultrasonography- fine needle aspiration EUS-FNA from portal vein thrombus. 
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Introduction 
 
Up to 70% of patients with HCC experience tumor invasion into the 
portal vein (PV) by direct venous extension or metastasis [1]. When 
patients display a liver mass expressive of HCC and PV thrombus 
that intensifies on arterial phase of computer tomography (CT) or 
magnetic resonance imaging (MRI), the diagnosis of a tumor 
thrombus is relatively easy. On the other hand, when there is no 
discrete or infiltrating liver mass or when there is nondiagnostic 
increase of AFP level or equivocal intensification of tumor thrombus, 
tumor thrombosis diagnosis is difficult. A definite diagnosis or 
exclusion of tumor thrombus becomes critically important in case of 
liver transplantation or a curative resection; thus, tissue diagnosis is 
always confirmatory [2,3]. The feasibility and safety of fine needle 
aspiration (FNA) of PV thrombus under transcutaneous 
ultrasonography guidance has been described by a number of case 
series. Yet, due to technical difficulties, this is not widely used [1]. 
However, although there are only few interventions with endoscopic 
ultrasonography (EUS)-FNA, it has been reported that it should be 
used as the first choice since it is easy to apply, safe and since it 
has a high chance of success [2,4]. In this paper, we presented 
three cases that had liver cirrhosis, mass and portal vein thrombosis 
in liver. We were not able to diagnose the cases through imaging 
methods, laboratory results or histopathologically, however, they 
were diagnosed with EUS-FNA from PV thrombus. 
  
  




48 year-old male patient was hospitalized with a complaint of 
abdominal pain and nausea that had been going on for about eight 
months. The patient had no peculiarity in his anamnesis and family 
history. The patient had been smoking for 10 package/years. His 
physical examination revealed icteric 2 cm long hepatomegaly and 4 
cm splenomegaly. His laboratory results were as follows: Glucose: 
86 mg/dl, Creatinine: 0.9 mg/dl, AST: 92 U/L, ALT: 89 U/L, ALP: 
139 U/L, GGT: 386 U/L, LDH:162 U/L, Total bilirubin: 6.3 mg/dl, 
Conjugated bilirubin: 6.0 mg/dl, Albumin:3.2 g/dl, Amylase: 1523 
U/L, Lipase: 1254 U/L, Wbc: 5060 mm 3 , Hct: 38.4%, 
Platelet:109.000 mm3 Prothrombrin time: 14 sec, AFP:4.1 ng/mL 
and HbsAg: positive. In his abdominal ultrasonography (USG) and 
portal vein doppler USG, the liver had a cirrhotic appearance and 
splenomegaly was found. His gastroscopy revealed grade III 
esophageal varicosis. His dynamic contrasted abdominal magnetic 
resonance (MR) showed intrahepatic bile ducts dillated, choledoch 
normal, acute pancreatitis and in fourth segment of the left lobe of 
the liver a mass without typical wash-out but intense contrast in the 
arterial phase with a size of 10x8 cm and his MR angiography 
showed thrombus on the portal vein left branch. The result of mass 
biopsy was reported as focal nodular hyperplasia. Tenofovir was 
started and his endoscopic ultrasonography (EUS) showed a mass 
with a diameter of 10 cm and thrombus on the portal vein in the left 
lobe of the liver. Biopsy was taken from the thrombus with 25 G 
FNA needle. The biopsy showed big irregular atypical cells in groups 
some of which were distributed alone and in some places looked like 
trabecular structures and he was diagnosed as HCC. The patient 





50-year-old male patient. The patient had been receiving antiviral 
treatment for 13 years with a diagnosis of chronic hepatitis B and he 
was under control. Five years ago, a mass with a diameter of 2 cm 
was found in the eighth segment of the liver. The patient was 
operated and his pathology was reported as HCC. The patient who 
developed abdominal pain in his follow-ups was hospitalized. The 
patient had no peculiarity in his anamnesis and family history. He 
had been using tenofovir 245 mg/day and had been smoking for 10 
package/years. His physical examination was normal. His laboratory 
findings were as follows: Glucose: 86 mg/dl, Creatinine: 0.9 mg/dl, 
AST: 92 U/L, ALT: 89 U/L, ALP: 139 U/L, GGT: 386 U/L, LDH:162 
U/L, Total bilirubin: 6.3 mg/dl, Conjugated bilirubin: 6.0 mg/dl, 
Albumin:3.2 g/dl, Wbc: 5060 mm3, Hct: 38.4%, Platelet:109.000 
mm3, Prothrombrin time: 14 sec, AFP:4.1 ng/mL and HbsAg: 
positive, HBV DNA: negative. His abdominal tomography (AT) 
showed a solid mass with a regular contour in the left lobe of the 
liver next to the lateral segment anterior. The mass had 
extrahepatic location, it had a size of 80x52 mm, it had a 
heterogeneous inner structure, it had intense contrast at arterial 
phase but it did not have typical wash-out. AT angiography showed 
thrombus at the portal vein left branch. The patient underwent EUS 
and biopsy was taken from the mass on the left lobe of the liver 
with 22 G needle and FNA biopsy was taken from the thrombus on 
the portal vein with 25G needle. The biopsy results of both the mass 
in the liver and the thrombus were HCC. The patient underwent 
radiofrequency embolisation and he was taken under control. 
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Case 3 
  
77-year-old male patient. The patient was diagnosed with chronic 
hepatitis B four years ago and started lamivudin 100 mg/day. The 
patient who did not come to his controls was hospitalized with 
complaints of swellings on the legs, asthenia and pain in joints. The 
patient had no peculiarity in his anamnesis and family history and 
he was not smoking or drinking. His physical examination revealed 
faintness, moderate edema, 2 cm splenomegaly and arthritis on the 
left toe and left ankle. His laboratory findings were as follows: 
Glucose: 86 mg/dl, Creatinine: 0.7 mg/dl, AST: 81 U/L, ALT: 95 U/L, 
ALP: 56 U/L, GGT: 28 U/L, LDH:217 U/L, Total bilirubin: 0.8 mg/dl, 
Conjugated bilirubin: 0.5 mg/dl,Albumin:3.3g/dl,Wbc:4550mm3, Hct: 
30.2%, Platelet:213.000mm3, Prothrombrin time: 18 sec, AFP:1.1 
ng/mL and HbsAg: positive , HBV DNA: 1.270.000 IU, Anti delta 
total (+) and HDV RNA (-). His abdominal MR showed cirrhotic liver, 
a mass lesion with a size of 70x45 mm on the seventh segment of 
the right lobe. T1A examination showed that the central of the mass 
lesion was hyperintense, its periphery was hypointense; 
postcontrasted examination showed that it did not show an obvious 
contrast but it showed diffusion limits. In the eighth segment of the 
right lobe of the liver, a centrally located 25x20 mm lesion was seen 
which extended to the inferior vena cava and caused tumor 
thrombus in the vena cava. EUS showed masses with diameters of 7 
cm and 2 cm on the seventh and eighth segments of the liver and 
thrombus that extended to the vena cava inferior. Biopsy was taken 
from the thrombus with 25 G FNA needle. Biopsy result showed 
HCC. The patient underwent radiofrequency embolisation and he 





Although hepatocellular carcinoma (HCC) is a fatal complication of 
cirrhosis, recent advances in treatment such as liver transplantation 
in select cases have turned HCC into a potentially curable disease. 
Attempts of curative treatment options can be made only when 
extensive vascular invasion or extrahepatic spread are absent. Since 
the present laboratory tests lack adequate sensitivity or specificity, 
HCC is usually diagnosed by radiologic imaging [2]. HCC can also be 
diagnosed through noninvasive radiologic imaging modalities, 
however, these techniques also do not have adequate accuracy 
when diagnoses are made without tissue sampling [5]. When a 
mass is found on imaging, increase alphafetoprotein (AFP) level 
(>200 ng/mL), or a rising AFP level has a very high positive 
predictive value in the diagnosis of HCC [2]. Yet, at the time of 
diagnosis 30% of patients have normal AFP levels and they usually 
remain low, even with advanced HCC [6]. AFP specificity is close to 
100% with such values; however, this causes sensitivity to fall by 
45% [7]. The positive predictive value (PPV) of AFP is low, with 
percentages ranging from 9% to 32% [8]. Although all our cases 
had tumoral portal vein thrombosis, AFP levels were normal. 
Conventional imaging studies such as abdominal US, CT and MRI 
cannot easily distinguish between benign and malignant vein 
thrombi. On imaging studies, portal vein tumor thrombosis (PVTT) 
appears as a low density plug within a dilated main or lobar portal 
vein. With contrast in the arterial phase, this plug enlarges and may 
have an arterial signal on Doppler ultrasound. Nontumor portal vein 
thrombosis does not enhance with contrast and does not have any 
Doppler signal but it has a similar appearance to PVTT [1, 3, 9]. In 
patients with cirrhosis, PVT may be associated with malignancy, 
inflammatory, and infectious diseases and hypercoagulable states. 
Iatrogenic intervention in cirrhosis can also cause PVT. PVT can also 
be provoked by endoscopic sclerotherapy of esophageal varices and 
percutaneous ablation or surgery therapies for HCC [1,3,9]. Except 
for malignancy, none of the afore mentioned causes are a 
contraindication for therapeutic intervention in HCC. In cirrhosis, 
malignant PVT is a usual complication of HCC and is an indicator of 
advanced tumoral stage. Thus, in order to make a definitive 
diagnosis, a fine needle aspiration biopsy is required in many cases. 
In all our three cases, imaging methods were not typical of HCC and 
PVTT. 
  
In a great number of previous studies, transabdominal (TA) US-
guided FNA has been shown to be effective and safe. In Dusenbery 
et al's study [10], in biopsies, 39 patients were reported to be 
positive (81.3%), 3 patients were reported to be dubiously positive 
(6.2%) and only 6 patients were reported to be negative (12.5%). 
However, although TAUS-FNA is effective and safe, its use in PVT in 
order to eliminate malignancy has not become routine. The reasons 
for this are a great number of tumor induced PVT cases being 
diagnosed with imaging techniques as a result of the development 
in CT and MRI, the difficulty of TAUS-FNA process due to obesity 
and assit in patients with liver cirrhosis, frequent complications such 
as biliary tract and arteriovenous injury and the distance between 
the skin and PV [2]. The first case report of EUS-guided FNA of the 
PV for diagnosis of HCC was published in 2004 by Lai and 
colleagues [11]. This was followed by a second report in 2007 by 
Storch et al. [12] EUS-guided FNA of the PV has certain advantages 
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over TA-US. The source of the ultrasound beam can be delivered 
within 2-3 cm of the PV by an echoendoscope which uses high 
frequency (10-12 mHz) ultrasound, provides excellent resolution 
and reliable visualization of the PV, its content, and surrounding 
tissue and organs. In addition, the FNA needle has to go only a 
short distance which causes the procedure to be quick and precise 
[2]. Avoiding the common bile duct and vasculature, particularly 
collateral vessels, the FNA needle can be positioned directly into the 
PVT. As a result, complications can be minimized, at least in theory. 
A lower potential for needle tract seeding is another advantage of 





As a conclusion, this study shows once more that EUS-FNA is an 
easy, safe and effective procedure. We recommend the use of EUS-
FNA in order to determine that HCC staging and PVT occurrence due 
to tumor especially in patients with liver cirrhosis who have been 
found to have mass and PVT in liver, in patients who cannot be 
diagnosed as HCC and PVTT with imaging techniques and laboratory 
results and in patients who undergo local treatment or surgical 
treatment following a diagnosis of HCC and develop PVT during 
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